Tardito et al. reported that in human sarcoma cells, glutamine synthetase contributed to the adaptation of tumor cells to ASNase, and that inhibition of glutamine synthetase enhanced the effect of ASNase [32]. The gene discussed is GLUL; the disease is sarcoma.